Urinalysis Testing Products Market is Segmented By Product Type (Instruments, Consumables), By Application (Urinary Tract Infections (UTI), Kidney diseases, Diabetes, Liver disease, Others), By End-User (Hospitals, Diagnostic Centers, Research laboratories, Homecare Settings), By Region (North America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Urinalysis Testing Products Market Overview
Urinalysis Testing Products market is estimated to reach at a high CAGR of 7.3 % during the forecast period (2023-2030).
A urinalysis is a urine examination. Urinary tract infections, kidney illness, and diabetes are among the disorders for which it is used to diagnose and treat. During a urinalysis, the appearance, concentration, and content of urine are all analyzed. Abnormal urine results may indicate sickness or illness.
Urinalysis Testing Products Market Scope
|
Metrics |
Details |
|
Market CAGR |
7.3% |
|
Segments Covered |
By product Type, By Application, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
To Know More Insights - Download Sample
Urinalysis Testing Products Market Dynamics
The factors such as the growing geriatric population and related disorders are expected to drive the market growth. And the ease of the urinalysis test and the detailed results are expected to drive the global urinalysis testing products market.
The growing geriatric population and related disorders are expected to drive the market growth
According to WHO, By 2030, one out of every six persons on the planet will be 60 years old or older. The number of people aged 60 and more is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of adults aged 60 and up will have doubled (2.1 billion). The number of people between 2020 and 2050, aged 80 and more is predicted to treble, reaching 426 million. In elderly people, urinary tract infection and asymptomatic bacteriuria are prevalent. It is difficult to tell the difference between a symptomatic urinary tract infection and asymptomatic bacteriuria in older persons, especially long-term care institutions because they're less likely to have localised genitourinary symptoms. In older persons, urinary tract infections (UTIs) are the most common type of bacterial infection. According to the National Institutes of Health, UTIs afflict about 10% of men and 20% of women over the age of 80.
A urinalysis and a urine culture with antibiotic susceptibility testing are the two most popular diagnostics for detecting UTIs: Urinalysis: A urinalysis consists of a series of physical, chemical, and microscopic tests performed on a urine sample. These tests look for bacteria and white blood cells, which are signs of infection. A higher number of WBCs in the urine under a microscope, as well as a positive leukocyte esterase test, could indicate an infection or inflammation in the urinary tract. They indicate a urinary tract infection if they are also accompanied by bacteria. During a urinalysis, the appearance, concentration, and content of urine are all analysed. Sickness or illness might be indicated by abnormal urine results. Urine can appear hazy rather than clear due to a urinary tract infection, for example. Renal impairment can be indicated by increased protein levels in the urine. Unusual urine findings frequently demand additional testing to pinpoint the source of the problem. As a result of rising in the elderly population and age-related disorders becoming more prevalent, there is going to be a significant increase in the market growth.
The ease of the urinalysis test and the detailed results it provides is expected to drive the global urinalysis testing products market
Most urinalyses include the patient urinating into a specimen cup, which can be done at home or a doctor's office. A sample is sometimes asked first thing in the morning since more concentrated pee results are easier to read. A urinalysis is merely a pee examination. It is a popular test that may be done in various places, including doctors' offices, urgent care centres, laboratories, hospitals, and even at home. A urine sample from the patient is collected in a specimen cup for a urinalysis test. Urinalysis testing usually only requires a modest sample of urine (30-60 mL). The sample can either be tested in a medical facility or sent to a laboratory for testing.
The abbreviation UA stands for Urinalysis. In general, UA is readily available and reasonably priced. It is also a straightforward test that can provide a wealth of information regarding various diseases and ailments. Because of the wealth of information that can be gathered about the health of the kidney or other internal disorders by this basic test, some clinicians refer to urinalysis as "a poor man's kidney Others." A macroscopic analysis can assess urine's physical appearance (colour, cloudiness, odour, and clarity). It can also be examined using chemical and molecular properties, as well as microscopic examination. Urinalysis can reveal signs and symptoms of diseases that have not yet manifested themselves. As a result, urinalysis is frequently used as part of routine health screening.
On March 6th, 2019, The FDA approved a smartphone-based at-home urine test that allows patients with chronic diseases, urinary tract infections, or high-risk pregnancies to track their health using a testing method as simple as shooting a smartphone selfie. Dip.io is a home-based urine test that the FDA has authorized. Through the Dip.io app, it allows smartphones to be used as a medical diagnostic tool.
Limitation and late results turnaround time of the test is expected to hamper the market growth
Many of the dipstick readings aren't reliable, and false-positive outcomes might occur. The test relies on the patient correctly collecting a sample, and if this is not done correctly, the results may be an error. Many urine abnormalities can be detected in healthy adults. In both men and women, a midstream clean-catch approach is usually sufficient. Although washing the external genitalia before surgery is frequently recommended in women, there is no evidence beneficial. Contamination rates were equal in specimens acquired with and without previous washing, according to a recent study. If urine cannot be studied immediately, it must be refrigerated; delays of more than two hours between collection and testing frequently result in inaccurate results.
The chemical reactions on the dipstick are complex, and oxidizing, reducing, and discolouring chemicals in the urine might impact them. As a result, dipstick testing frequently yields misleading positive and negative results. It is vital to collect urine cleanly and examine the pee thoroughly to acquire reliable dipstick results. To analyze anomalous findings, it is necessary to have a thorough understanding of the concepts of dipstick testing. If the urine dipstick results indicate hematuria, proteinuria, or a urinary tract infection, urine microscopy should be done to confirm the findings. The people who might be at risk are those who need a catheterization to get a urine sample. The most frequent type of catheter used in persons with urine retention, urinary incontinence, or other diseases that interfere with normal urination is a Foley catheter, a flexible tube put into the urethra to drain the bladder. Infection, bleeding, discomfort, and bladder injury are all concerns associated with urinary catheterization.
COVID-19 Impact Analysis
COVID-19 has affected the healthcare industry moderately. To stop its spread, government-imposed lockdown. People are fearful they may experience occupational effects and negative health from the COVID-19 pandemic. The pandemic disrupted many diagnosis procedures, as well as the approvals. This has moderately affected the global urinalysis testing products market due to limitations to avoid transmission of COVID.
Urinalysis Testing Products Market Segment Analysis
Based on product type, instruments are expected to dominate the global urinalysis testing products market
Urinalysis is a common diagnostic screening test used in clinical laboratories to diagnose and monitor nephrological and urological disorders. Until recently, the most widely accepted urinalysis approach was microscopic urine sediment analysis. This time-consuming process, however, is linked to a high rate of analytical errors. In the last 25 years, new automated technologies and informatics have considerably lowered the labor intensity of urinalysis while also opening up new technical possibilities. A urine analyser is a device that does automatic urine testing in a clinical context. Bilirubin, protein, glucose, and red blood cells are among the analytes that the units can detect and quantify. Urine strip readers, a form of reflectance photometer that can process hundreds of strips per hour, are found in several models.
Automated urinalysis has made great progress thanks to new technology advancements. Reflectometry has made it possible to read urinary test strips quantitatively, and complementary metal-oxide-semiconductor (CMOS) technology has improved analytical sensitivity and shown promise in microalbuminuria testing. Microscopy-based urine particle analysis has advanced significantly in recent decades, allowing clinical laboratories to achieve high throughput. Automated urinalysis can be used for urinary tract screening and diagnosing and monitoring a wide range of nephrological and urological disorders; newer uses show promise for early detection of urothelial carcinoma. At the same time, the introduction of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) has made it possible to identify urine infections quickly. The mechanical integration of test strip readers and particle analysis in urinalysis has been made possible by automation and process reduction.
On 11th October 2019, LAURA XL was a fully automated urine analyzer with digital microscopy and reliable urine strip analysis. It evaluates 10 chemical parameters, and 16 sediment classifications automatically were launched by Erba Mannheim.
Urinalysis Testing Products Market Geographical Share
North America region accounted for the largest market share in the global urinalysis testing products market
With increasing UTI problems and the latest product launches by major key players, this region is assumed to dominate the market.
In the United States, urinary tract infections (UTIs) are very frequent. Urinary tract infections (UTIs) are the second most prevalent type of infection in the body, accounting for more than 8 million hospital visits each year. A UTI affects about 10 out of every 25 women and 3 out of every 25 men at some point in their lives. A urinary tract infection (UTI) occurs when an infection develops in the urinary tract. Urinalysis is the most frequently used test for the evaluation of potential urinary tract infection (UTI). In the U.S, urinalysis cost ranges from $30 to $247 depending on the depth of the panel.
On August 10th, 2020, Sysmex America, Inc. announced an exclusive agreement with Siemens Healthineers to distribute and service the Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use in North America. To assist assure optimal efficiency and uniform testing, the CLINITEK Novus Automated Urine Analyzer combines dry-pad urine chemistry technology with a cassette test format.
Urinalysis Testing Products Market Companies and Competitive Landscape
Urinalysis Testing Products Market is moderately competitive with the increasing incidence of diseases and demand for diagnosis equipment.
Some of the major key players in the global urinalysis testing products market are Erba Mannheim, Siemens Healthineers, URIT Medical Electronic Ltd, Roche Diagnostics, Beckman Coulter, Sysmex Corporation, DIRUI, Arkray Inc., Cardinal Health and EKF Diagnostics.
